Role of fibroblast growth factor 21 in biology of glucagon

Diabetes

Volumn 62, Issue 5, 2013, Pages 1376-

  Berglund, Eric D ^a   Unger, Roger H ^b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; FIBROBLAST GROWTH FACTOR 21; GLUCAGON; IUB 288; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; BIOLOGY; DIABETES MELLITUS; INSULIN DEFICIENCY; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCAGON; HEPATOCYTES; HUMANS; MALE; RECEPTORS, GLUCAGON;

EID: 84876556455     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1840     Document Type: Note

References (7)

1. Habegger KM, Stemmer K, Cheng C, et al. Fibroblast growth factor 21 mediates specific glucagon actions. Diabetes 2013;62:1453-1463
2. Arafat AM, Kaczmarek P, Skrzypski M, et al. Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? Diabetologia 2013;56:588-597
3. Marks V, Samols E. Glucagon test for insulinoma: a chemical study in 25 cases. J Clin Pathol 1968;21:346-352
4. Unger RH. The Banting Memorial Lecture 1975. Diabetes and the alpha cell. Diabetes 1976;25:136-151
5. Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 2011;60:391-397
6. Berglund ED, Li CY, Bina HA, et al. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology 2009;150:4084-4093
7. Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005;115:1627-1635 (Pubitemid 40814671)